1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. AVITA MEDICAL INC
AVITA Medical Inc
XNAS: RCEL
13.10-0.26(-1.95%)
524.5K
XNAS Volume

XNAS 14 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

AVITA Medical Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for AVITA Medical Inc share price target, revenues, EPS, net income and more

AVITA Medical Inc quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue AVITA Medical Inc Jun-2026 Quarterly Revenue is $22 Million which is growth of 17.8% YoY.

  • POSITIVE

    Quarterly Net Profit AVITA Medical Inc Jun-2026 Quarterly Net Profit is $-8 Million which is growth of 22.8% YoY.

AVITA Medical Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
21.719.317.617.118.418.518.419.615.211.114.213.611.8
Cost Of Rev.
3.93.53.33.23.52.82.33.22.11.51.82.12.2
Gross Profit
17.815.714.313.91515.716.116.413.19.612.411.59.6
⌄
24.624.524.72326.127.526.130.228.726.824.720.820.7
Operating Profit
-6.9-8.8-10.4-9.2-11.2-11.8-10-13.8-15.6-17.2-12.3-9.3-11.2
-1.5-1.4-1.3-1.3-1.3-1.2-1.3-1.4-1.4-1.4-1.1-0-0
Profit Before Tax
-7.6-10.6-11.6-13.2-9.9-13.9-11.6-16.2-15.4-18.6-7.1-8.7-10.4
Tax
0-0-0000-000000
⌄
-7.7-10.6-11.6-13.2-9.9-13.9-11.6-16.2-15.4-18.7-7.1-8.7-10.4
Diluted NI Avail to Com Stockholders Ann.
-7.7-10.6-11.6-13.2-9.9-13.9-11.6-16.2-15.4-18.7-7.1-8.7-10.4
Basic EPS
-0.3-0.4-0.4-0.5-0.4-0.5-0.4-0.6-0.6-0.7-0.3-0.3-0.4
Diluted EPS After ExtraOrdinary
-0.3-0.4-0.4-0.5-0.4-0.5-0.4-0.6-0.6-0.7-0.3-0.3-0.4
Number Of Shares End
30.830.530.428.426.426.326.22625.825.624.225.425.2
Net Income Continuing Discontinued Operations
-7.7-10.6-11.6-13.2-9.9-13.9-11.6-16.2-15.4-18.7-7.1-8.7-10.4
Normalized Income
-5.9-8.8-10.8-10.7-8.3-11.8-8.7-11.1-13.7-15.9-12.7-6.8-9.5
Interest Income
-------------
Interest
1.51.41.31.31.31.21.31.41.41.41.100
Net Interest Income
-1.5-1.4-1.3-1.3-1.3-1.2-1.3-1.4-1.4-1.4-1.1-0-0
EBIT
-6.2-9.2-6.7-11.9-8.7-12.6-6.3-14.9-14-17.3-6.1-8.7-10.4
EBITDA
-5.6-8.6-6-11.3-8.1-12.1-5.9-14.6-13.8-17.1-6-8.5-10.2
Reconciled Cost Of Rev.
3.93.53.33.23.52.82.33.22.11.51.82.12.2
Reconciled Depr.
0.60.60.70.60.60.50.40.30.20.20.20.20.2
Profit From Continuing Operations
-7.7-10.6-11.6-13.2-9.9-13.9-11.6-16.2-15.4-18.7-7.1-8.7-10.4
Normalized EBITDA
-5.6-8.6-9.7-11.3-8.1-12.1-9.9-14.6-13.8-17.1-5.7-8.5-10.2
*All financials are in USD Million and price data in USD

AVITA Medical Inc competitor comparison and performance snapshot within industry

AVITA Medical Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • POSITIVE

    Annual Revenue AVITA Medical Inc Dec-2025 Annual Revenue is $72 Million which is growth of 11.5% YoY.

  • POSITIVE

    Annual Net Profit AVITA Medical Inc Dec-2025 Annual Net Profit is $-49 Million which is growth of 21.4% YoY.

AVITA Medical Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Jun '21Jun '20Jun '19Jun '18Jun '17Jun '16Jun '15
27.7%
38%
 71.664.350.134.429.214.35.40.90.90.82.1
Cost Of Rev. Ann.
28.7%
33.7%
13.912.89.17.86631.20.40.40.30.6
Gross Profit Ann.
27.5%
39.1%
61.758.855.242.428.423.311.34.20.50.50.51.5
Operating Exp. Ann.
22%
13.4%
96.9101.4111.88555.949.85429.313.715.510.87.7
Operating Profit Ann.
-
-
-35.2-42.5-56.6-42.7-27.5-26.5-42.7-25-13.2-15-10.3-6.1
-
-
-5.4-5-5.4-1.1-0-0-0-0-00.10.10
Other Exp. Ann.
-
-
 -10.28.50.900.70.30.15.31.80.1
PBT Ann.
-
-
-43.1-48.6-61.8-35.3-26.6-26.5-42-24.8-13.2-9.7-8.4-6
Tax Ann.
-
-
000.10.100-0.1-1-0.8-0.7-0.5
⌄
-
-
-43.1-48.6-61.8-35.4-26.7-26.6-42-24.6-12.1-8.9-5.8-5.5
Diluted NI Avail to Com Stockholders Ann.
-
-
-43.1-48.6-61.8-35.4-26.7-26.6-42-24.6-12.1---
EPS Ann.
-
-
 -1.7-2.4-1.4-1.1-1.2-2.1-2-1.4-1.2-1-1.5
Diluted EPS Ann.
-
-
 -1.7-2.4-1.4-1.1-1.2-2.1-2-1.4-1.2-1-1.5
Number Of Shares End
6.6%
7.3%
 30.426.224.225.124.921.493.663.935.529.824.1
Total Exp. Ann.
22.6%
14.9%
 114.1120.892.861.955.856.930.414.115.911.18.2
Net Income Continuing Discontinued Operations Ann.
-
-
-43.1-48.6-61.8-35.4-26.7-26.6-42-24.6-12.1-8.9-5.8-5.5
Normalized Income Ann.
-
-
-36.1-41.7-50.5-35.3-21.2-22.2-29.7-23.4-11.1-7.6-6.8-6
Interest Income Ann.
-
-
 --------0.10.10
Interest Ann.
-
-
5.455.41.1000000
EBITDA Ann.
-
-
-31.4-41.3-55.4-33.8-26.1-25.8-41.5-25-13.7-9.4-8.3-6.4
Reconciled Cost Of Rev. Ann.
28.7%
33.7%
13.912.89.17.86631.20.40.40.30.6
Reconciled Depr. Ann.
58.7%
36.9%
2.52.41.10.60.60.70.50.30.1---
Profit From Continuing Operations Ann.
-
-
-43.1-48.6-61.8-35.4-26.7-26.6-42-24.6-12.1---
Normalized EBITDA Ann.
-
-
-35.2-41.2-55.3-33.5-26.1-25.8-41.5-24.5-13-9.6-8.4-6.1
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
11.4%
2Y CAGR
19.5%
3Y CAGR
27.7%
5Y CAGR
38%
7Y CAGR
86.9%
10Y CAGR
42.3%
Total Revenue Annual growth is lower than historical averages.
Operating Exp. Ann.
1Y CHG
-9.3%
2Y CAGR
9.2%
3Y CAGR
22%
5Y CAGR
13.4%
7Y CAGR
33.1%
10Y CAGR
29.4%
Operating Expenses Annual Cr is falling faster than historical averages.

AVITA Medical Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • NEGATIVE

    Total Shareholders Fund AVITA Medical Inc Dec-2025 Total Shareholders Fund is $-17 Million which is growth of -470.1% YoY.

  • NEGATIVE

    Total Assets AVITA Medical Inc Dec-2025 Total Assets is $56 Million which is growth of -29.3% YoY.

AVITA Medical Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Jun '21Jun '20Jun '19Jun '18Jun '17Jun '16Jun '15
-16.9%
-7.3%
56.479.7111.698.3125.582.525.716.95.96.44.2
⌄
75.5%
48.5%
7375.262.613.59.910.14.9321.30.9
⌄
-
-
-16.74.549.184.7115.772.420.9143.95.13.2
Total Capitalization Ann.
-
-
-16.746.788.984.7115.772.420.9143.95.13.2
Tangible Assets Ann.
-
-
-22.3-1.148.684.3115.27220.6143.95.13.2
Working Capital Ann.
-
-
-27.236.890.876.8113.970.719.813.53.65.13.1
Invested Capital Ann.
-32.3%
-18.3%
26.346.788.984.7115.772.420.9143.95.13.2
Tangible Book Value Ann.
-
-
-22.3-1.148.684.3115.27220.6143.95.13.2
Borrowings Ann.
271.4%
89.2%
46.14642.40.90.91.900.1---
Net Debt Ann.
-
-
32.728.217.7--------
Share Issued Ann.
6.7%
7.3%
30.626.425.725.224.921.593.663.935.529.824.1
Number Of Shares End
6.6%
7.3%
30.426.224.225.124.921.493.663.935.529.824.1
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
-29.2%
2Y CAGR
-28.9%
3Y CAGR
-16.9%
5Y CAGR
-7.3%
7Y CAGR
18.8%
10Y CAGR
29.7%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
210.4%
2Y CAGR
117.9%
3Y CAGR
80.3%
5Y CAGR
52.1%
7Y CAGR
55.1%
10Y CAGR
52.9%
Total Current Liabilities Annual Cr growth is higher than historical averages.

AVITA Medical Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • NEGATIVE

    Book Value Per Share AVITA Medical Inc Book Value Per Share is $-1 which is growth of -418.5% YoY.

  • NEUTRAL

    ROE AVITA Medical Inc ROE is 0% which is growth of 0% YoY.

AVITA Medical Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Jun '21Jun '20Jun '19Jun '18Jun '17Jun '16Jun '15
RoA Ann. %
-
-
--64.64%-33.71%-24.89%-25.57%-77.70%-115.51%-106.44%-143.63%-109.60%-98.58%
ROE Ann. %
-
-
--230.96%-52.89%-28.16%-28.27%-90.13%-141.44%-135.64%-195.41%-139.10%-129.22%
ROIC %
-
-
--19.3-7.9-6.1-4-17.4-----
OPM Ann. %
-
-
-59.40%-88.08%-85.07%-79.91%-90.79%-299.23%-464.08%-1,497.01%-1,651.50%-1,376.07%-290.53%
Inventory Turnover Ratio Ann.
-
-
-1.422.84.33.21.50.50.40.41
Asset Turnover Ann. %
-
-
-0.70.50.30.30.30.30.10.20.10.4
Working Capital Turnover Ann.
-
-
-2.61.70.60.50.30.20.30.10.30.20.7
Quick Ratio Ann.
-
-
-2.47.47.916.19.95.15.22.341.4
Current Ratio Ann.
-
-
-2.87.98.216.410.25.55.72.94.94.3
Interest Coverage Ratio Ann.
-
-
--10.5-29.9-1,663.3-1,205.6-1,272.5-934.7-672.5-983.7-535,420.1-597,011.6
LT Debt To Equity Ann.
-
-
-100.9000---
*All financials are in USD Million and price data in USD

AVITA Medical Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • POSITIVE

    Cash From Operating Activity AVITA Medical Inc Dec-2025 Cash From Operating Activity is $-31 Million which is growth of 36.3% YoY.

  • POSITIVE

    Net Cash Flow AVITA Medical Inc Dec-2025 Net Cash Flow is $-4 Million which is growth of 52.8% YoY.

AVITA Medical Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Jun '21Jun '20Jun '19Jun '18Jun '17Jun '16Jun '15
-
-
-31.2-48.9-38-19.1-25.9-22.8-19.3-12---
-
-
12.537.41.6-19.3-1.2-0.9-1.3-0.40.2-0-0
154.9%
-28%
14.93.540.40.964.177.128.920.56.374.3
Cash Plus Cash Eqv. End Of Year Ann.
-17.6%
-32.7%
10.214.122.118.211173.820.310.92.93.12.3
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-3.8-8.14-37.53753.58.48.1-0.11-0.7
Cash Plus Cash Eqv. Begin Of Year Ann.
-36.7%
-7.1%
14.122.118.255.773.820.410.42.83.22.22.8
Income Tax Paid Supplemental Data Ann.
-
-
-0000------
Interest Paid Supplemental Data Ann.
-
-
-5.41.100-----
Capex Ann.
-
-
-1.7-9.3-1.5-0.5-1.2-0.9-1.3-0.4-0.3-0-0
Issuance Of Capital Stock Ann.
-
-28.9%
14.8--69.181.731.521.977.54.7
Issuance Of Debt Ann.
-
-
-38.8--------
Repayment Of Debt Ann.
-
-
----0-0---
Repurchase Of Capital Stock Ann.
-
-
-----------
Free Cash Flow Ann.
-
-
-32.9-58.3-39.5-19.6-27.1-23.6-20.9-13.1-7-7.9-6.5
*All financials are in USD Million and price data in USD
Cash from Investing Act. Ann.
1Y CHG
-66.6%
2Y CAGR
179.5%
Cash from Investing Activity Annual is falling faster than historical averages.
Cash from Financing Act. Ann.
1Y CHG
325.7%
2Y CAGR
-39.3%
3Y CAGR
154.9%
5Y CAGR
-28%
7Y CAGR
-4.5%
10Y CAGR
13.2%
Cash from Financing Annual Activity growth is higher than historical averages.